Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. https://www.biorxiv.org/content/10.1101/2023.02.07.527498v1?med=mas
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. https://www.biorxiv.org/content/10.1101/2023.02.07.527498v1?med=mas